Amplify Weight Loss Drug & Treatment ETF

Shareclass

Amplify Weight Loss Drug & Treatment ETF (THNR)

Type

Exchange-traded fund

Manager

Amplify ETFs

Gender equality score

/ 100 points

Overall score

Average Equileap Gender Equality Score of fund holdings, weighted by market value

Group ranking

87.8

percentile

Universe: Groups

Group: Sector Equity Funds

Ranking: 107 out of 867 funds

See more funds from this group

All funds

Groups

See the impact of your investments

Regular updates on sustainability risks and ethical concerns in everyday investment products

Sustainability report card

As You Sow’s Invest Your Values report card grades mutual funds on environmental and social issues, including climate change, gender equality, and weapon investments. Click through to get more details on each issue.

Amplify Weight Loss Drug & Treatment ETF THNR

Environment

Fossil fuels

Investments in coal, oil, and natural gas energy and utility companies, and related financial companies

Deforestation

Investments in deforestation-risk agricultural commodities, and related financial companies and consumer brands

Social

Gender equality

Gender equality group ranking, based on Equileap company data

Civilian firearms

Investments in civilian firearms manufacturers, and related gun retailers

Prison industrial complex

Investments in prisons and borders industry, including private prison operators

Military weapons

Investments in military arms manufacturers and services companies, including nuclear weapon manufacturers and servicers

Tobacco

Investments in tobacco and e-cigarette manufacturers, and tobacco-promoting entertainment companies

Search more funds

Top scoring holdings

The top 10 holdings in this portfolio with the best scores on the Equileap Gender Scorecard. In the case of ties, the holding with more assets invested is listed higher.

1. AstraZeneca PLC ADR
4.69% of assets
$155,066 invested
2. Novo Nordisk AS ADR
13% of assets
$433,653 invested
3. Merck & Co Inc
4.5% of assets
$148,589 invested
4. Amgen Inc
4.65% of assets
$153,606 invested
5. Roche Holding AG
4.78% of assets
$157,959 invested
6. Thermo Fisher Scientific Inc
4.24% of assets
$140,283 invested
7. Teva Pharmaceutical Industries Ltd ADR
4.71% of assets
$155,565 invested
8. Pfizer Inc
4.76% of assets
$157,444 invested
9. Eli Lilly and Co
17% of assets
$555,551 invested
10. West Pharmaceutical Services Inc
4.72% of assets
$155,932 invested

Bottom scoring holdings

The bottom 10 holdings in this portfolio with the worst scores on the Equileap Gender Scorecard. In the case of ties, the holding with more assets invested is listed higher.

1. Viking Therapeutics Inc
1.65% of assets
$54,680 invested
2. Zealand Pharma AS
2.35% of assets
$77,760 invested
3. Mitsubishi Chemical Group Corp
3.3% of assets
$108,998 invested
4. Ypsomed Holding AG
1.06% of assets
$34,876 invested
5. Chugai Pharmaceutical Co Ltd
6.45% of assets
$213,196 invested
6. Bachem Holding AG
1.31% of assets
$43,197 invested
7. Hims & Hers Health Inc Ordinary Shares - Class A
4.07% of assets
$134,353 invested
8. Gerresheimer AG
1.57% of assets
$51,723 invested
9. West Pharmaceutical Services Inc
4.72% of assets
$155,932 invested
10. Eli Lilly and Co
17% of assets
$555,551 invested

Find sustainably-invested mutual funds and ETFs

Top-scoring funds

Search for funds from your 401(k), retirement plan, or personal portfolio

Financial performance

Performance data provided by

Find more financial data on THNR at Morningstar.com

Gender Equality and Returns

Less than one year of returns available

Benchmarking tool

Current fund

THNR

Amplify Weight Loss Drug & Treatment ETF

Family

Amplify ETFs

Category

Health

Find another fund

vs.

Benchmark

ACWI

iShares MSCI ACWI ETF

Family

iShares from BlackRock

Category

Global Large-Stock Blend

Change benchmark

Fund comparison settings

Investment timeline

Performance as of: 4/30/25

Less than one year of returns available

Benchmark

Suggested: MSCI ACWI

Fund comparison results

Compared to the benchmark, this fund has:

Less than one year of returns available

Higher overall gender equality score

1 / 100 points higher

Higher gender balance in leadership and workforce score

1 / 40 points higher

Same equal compensation and work life balance score

0 / 30 points

Lower policies promoting gender equality score

1 / 20 points lower

Same commitment, transparency, and accountability score

0 / 10 points

Current fund

THNR

Amplify Weight Loss Drug & Treatment ETF

Family

Amplify ETFs

Category

Health

Find another fund

vs.

Benchmark

ACWI

iShares MSCI ACWI ETF

Family

iShares from BlackRock

Category

Global Large-Stock Blend

Change benchmark

Fund comparison settings

Investment timeline

Performance as of: 4/30/25

Less than one year of returns available

Benchmark

Suggested: MSCI ACWI

Fund comparison results

Compared to the benchmark, this fund has:

Less than one year of returns available

Higher overall gender equality score

1 / 100 points higher

Higher gender balance in leadership and workforce score

1 / 40 points higher

Same equal compensation and work life balance score

0 / 30 points

Lower policies promoting gender equality score

1 / 20 points lower

Same commitment, transparency, and accountability score

0 / 10 points

Current fund

THNR

Amplify Weight Loss Drug & Treatment ETF

Family

Amplify ETFs

Category

Health

Find another fund

vs.

Benchmark

ACWI

iShares MSCI ACWI ETF

Family

iShares from BlackRock

Category

Global Large-Stock Blend

Change benchmark

Fund comparison settings

Investment timeline

Performance as of: 4/30/25

Less than one year of returns available

Benchmark

Suggested: MSCI ACWI

Fund comparison results

Compared to the benchmark, this fund has:

Less than one year of returns available

Higher overall gender equality score

1 / 100 points higher

Higher gender balance in leadership and workforce score

1 / 40 points higher

Same equal compensation and work life balance score

0 / 30 points

Lower policies promoting gender equality score

1 / 20 points lower

Same commitment, transparency, and accountability score

0 / 10 points

Month-end trailing returns

Performance as of date: 4/30/25

Morningstar suggested benchmark: MSCI ACWI NR USD

Annualized returns

Gender-lens analysis

1-yr

3-yr

5-yr

10-yr

This fund
THNR - Amplify Weight Loss Drug & Treatment ETF

56 / 100 points

Benchmark

12%

10%

13%

8.76%

55 / 100 points

Fund compared to benchmark

Less than one year of returns available

1 / 100 points higher

Find more financial data on THNR at Morningstar.com

What's next?

Learn how to make a change and move your money

Get started with our action toolkit

Action toolkit

Ask your employer about gender-lens investing in your retirement plan

Use our toolkit

Find socially responsible funds that invest in gender equality

Find top-scoring funds

Learn more about As You Sow's Invest Your Values program

Invest Your Values

Visit Fossil Free Funds to measure the climate risk of this portfolio

See climate risk

Disclaimer: As You Sow is not an investment adviser

As You Sow is not an investment adviser as that term is defined under federal and state (California) laws and regulations. As You Sow is a tax-exempt, nonprofit organization dedicated to educating and empowering shareholders to change corporations for the good through the collection, analysis and dissemination of relevant information to the public, free of charge. As You Sow does not provide financial planning, legal or tax advice. Nothing on this website shall constitute or be construed as an offering of financial instruments, or as investment advice or investment recommendations.
See our full disclaimer